{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:28:56Z","timestamp":1779164936370,"version":"3.51.4"},"reference-count":253,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>G protein-coupled receptors (GPCRs) are plasma membrane proteins associated with an array of functions. Mutations in these receptors lead to a number of genetic diseases, including diseases involving the endocrine system. A particular subset of loss-of-function mutant GPCRs are misfolded receptors unable to traffic to their site of function (<jats:italic>i.e.<\/jats:italic> the cell surface plasma membrane). Endocrine disorders in humans caused by GPCR misfolding include, among others, hypo- and hyper-gonadotropic hypogonadism, morbid obesity, familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, X-linked nephrogenic diabetes insipidus, congenital hypothyroidism, and familial glucocorticoid resistance. Several <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> experimental approaches have been employed to restore function of some misfolded GPCRs linked to endocrine disfunction. The most promising approach is by employing pharmacological chaperones or pharmacoperones, which assist abnormally and incompletely folded proteins to refold correctly and adopt a more stable configuration to pass the scrutiny of the cell\u2019s quality control system, thereby correcting misrouting. This review covers the most important aspects that regulate folding and traffic of newly synthesized proteins, as well as the experimental approaches targeted to overcome protein misfolding, with special focus on GPCRs involved in endocrine diseases.<\/jats:p>","DOI":"10.3389\/fendo.2022.934685","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T05:33:02Z","timestamp":1661405582000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Alfredo","family":"Ulloa-Aguirre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Zari\u00f1\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Guti\u00e9rrez-Sagal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Xiong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/endo.142.1.7919","article-title":"Minireview: Insights into G protein-coupled receptor function using molecular models","volume":"142","author":"Gershengorn","year":"2001","journal-title":"Endocrinology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2518","article-title":"Structural diversity of G protein-coupled receptors and significance for drug discovery","volume":"7","author":"Lagerstrom","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00431","article-title":"GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets","volume":"9","author":"Insel","year":"2018","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1124\/mol.117.111062","article-title":"G Protein-coupled receptors as targets for approved drugs: How many targets and how many drugs","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B7","first-page":"87","article-title":"G Protein-coupled receptors and the G protein family","volume-title":"Handbook of physiology. section 7: The endocrine system. 1: Cellular endocrinology","author":"Ulloa-Aguirre","year":"1998"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0188-0128(99)00041-X","article-title":"Structure-activity relationships of G protein-coupled receptors","volume":"30","author":"Ulloa-Aguirre","year":"1999","journal-title":"Arch Med Res"},{"key":"B9","first-page":"1","article-title":"Membrane signaling in health and disease","volume-title":"Reference module in neuroscience and biobehavioral psychology","author":"Ulloa-Aguirre","year":"2018"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.08.002","article-title":"Regulation, signaling, and physiological functions of G-proteins","volume":"428","author":"Syrovatkina","year":"2016","journal-title":"J Mol Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-96704-2_10","article-title":"Evolving view of membrane trafficking and signaling systems for G protein-coupled receptors","volume":"57","author":"Sposini","year":"2018","journal-title":"Prog Mol Subcell Biol"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-819132-3.00012-9","article-title":"Protein homeostasis and regulation of intreacellular trafficking of G protein-coupled receptors","volume-title":"Protein homeostasis deseases","author":"Ulloa-Aguirre","year":"2020"},{"key":"B13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/B978-0-12-819801-8.00018-1","article-title":"Intracellular trafficking of G protein-coupled receptors to the cell surface plasma membrane in health and disease","volume-title":"Cellular endocrinology in health and disease","author":"Ulloa-Aguirre","year":"2021"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-0111-6","article-title":"Mammalian olfactory receptors: pharmacology, G protein coupling and desensitization","volume":"66","author":"Kato","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pharmthera.2004.08.008","article-title":"Mutant G-protein-coupled receptors as a cause of human diseases","volume":"104","author":"Schoneberg","year":"2004","journal-title":"Pharmacol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2004.00232.x","article-title":"Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease","volume":"5","author":"Ulloa-Aguirre","year":"2004","journal-title":"Traffic"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/cb600360h","article-title":"G-Protein-coupled receptor trafficking: understanding the chemical basis of health and disease","volume":"1","author":"Ulloa-Aguirre","year":"2006","journal-title":"ACS Chem Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)01575-3","article-title":"Pharmacological chaperones: a new twist on receptor folding","volume":"21","author":"Morello","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2741\/3290","article-title":"Targeting of G protein-coupled receptors to the plasma membrane in health and disease","volume":"14","author":"Ulloa-Aguirre","year":"2009","journal-title":"Front Biosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1480367","article-title":"Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders","volume":"11","author":"Hou","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2003.12.008","article-title":"Principles of protein folding, misfolding and aggregation","volume":"15","author":"Dobson","year":"2004","journal-title":"Semin Cell Dev Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0216781","article-title":"Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions","volume":"110","author":"Horwich","year":"2002","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0197-0186(02)00196-1","article-title":"Neurodegenerative disorders of protein aggregation","volume":"43","author":"Shastry","year":"2003","journal-title":"Neurochem Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2004.05.003","article-title":"Pharmacological chaperones: potential treatment for conformational diseases","volume":"15","author":"Bernier","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807119","article-title":"VX-659-Tezacaftor-Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1021\/bi702209s","article-title":"Misfolding of the cystic fibrosis transmembrane conductance regulator and disease","volume":"47","author":"Cheung","year":"2008","journal-title":"Biochemistry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"246ra96","DOI":"10.1126\/scitranslmed.3008680","article-title":"Potentiator ivacaftor abrogates pharmacological correction of DeltaF508 CFTR in cystic fibrosis","volume":"6","author":"Cholon","year":"2014","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1042\/bse0500233","article-title":"Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy","volume":"50","author":"Kim Chiaw","year":"2011","journal-title":"Essays Biochem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1053\/prrv.2000.0124","article-title":"Therapeutic strategies to correct malfunction of CFTR","volume":"2","author":"Lim","year":"2001","journal-title":"Paediatr Respir Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.055608","article-title":"A small-molecule modulator interacts directly with deltaPhe508-CFTR to modify its ATPase activity and conformational stability","volume":"75","author":"Wellhauser","year":"2009","journal-title":"Mol Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.6b00853","article-title":"Direct measurement of trafficking of the cystic fibrosis transmembrane conductance regulator to the cell surface and binding to a chemical chaperone","volume":"56","author":"Zhang","year":"2017","journal-title":"Biochemistry."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0955-0674(95)80009-3","article-title":"Quality control in the secretory pathway","volume":"7","author":"Hammond","year":"1995","journal-title":"Curr Opin Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2000.0759","article-title":"Quality control in the secretory assembly line","volume":"356","author":"Helenius","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2174\/1389203013381134","article-title":"Chaperone-assisted protein folding in the cell cytoplasm","volume":"2","author":"Houry","year":"2001","journal-title":"Curr Protein Pept Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068408","article-title":"Molecular chaperones in the cytosol: from nascent chain to folded protein","volume":"295","author":"Hartl","year":"2002","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2741\/2257","article-title":"Molecular chaperones: multiple functions, pathologies, and potential applications","volume":"12","author":"Macario","year":"2007","journal-title":"Front Biosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0092-8674(00)81223-4","article-title":"Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins","volume":"94","author":"Glover","year":"1998","journal-title":"Cell."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001346","article-title":"Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans","volume":"10","author":"Duennwald","year":"2012","journal-title":"PloS Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/355033a0","article-title":"Protein folding in the cell","volume":"355","author":"Gething","year":"1992","journal-title":"Nature."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5282.1725","article-title":"ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway","volume":"273","author":"Hiller","year":"1996","journal-title":"Science."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2468","article-title":"Diversity of degradation signals in the ubiquitin-proteasome system","volume":"9","author":"Ravid","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385952-5.00008-7","article-title":"Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors","volume":"62","author":"Conn","year":"2011","journal-title":"Adv Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2009.12.008","article-title":"Life and death of a BiP substrate","volume":"21","author":"Otero","year":"2010","journal-title":"Semin Cell Dev Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV118.002806","article-title":"Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling","volume":"294","author":"Genest","year":"2019","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV118.002810","article-title":"Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones","volume":"294","author":"Mayer","year":"2019","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/370111a0","article-title":"Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones","volume":"370","author":"Frydman","year":"1994","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/356683a0","article-title":"Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding","volume":"356","author":"Langer","year":"1992","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2009.06.030","article-title":"Bridging the gap: from protein misfolding to protein misfolding diseases","volume":"583","author":"Luheshi","year":"2009","journal-title":"FEBS Lett"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.49.30873","article-title":"BiP, a major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+","volume":"272","author":"Lievremont","year":"1997","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.40.25552","article-title":"The chaperone BiP\/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion","volume":"273","author":"Yang","year":"1998","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV118.002804","article-title":"The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: Getting by with a little help from ERdj friends","volume":"294","author":"Pobre","year":"2019","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2005.12.016","article-title":"Role of n-glycan-dependent quality control in the cell-surface expression of the AT1 receptor","volume":"340","author":"Lanctot","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/me.2003-0406","article-title":"Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors","volume":"18","author":"Mizrachi","year":"2004","journal-title":"Mol Endocrinol"},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)32083-5","article-title":"Structure and function in rhodopsin. requirements of a specific structure for the intradiscal domain","volume":"269","author":"Anukanth","year":"1994","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2002.03192.x","article-title":"Association of the thyrotropin receptor with calnexin, calreticulin and BiP. efects on the maturation of the receptor","volume":"269","author":"Siffroi-Fernandez","year":"2002","journal-title":"Eur J Biochem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00187","article-title":"The endoplasmic reticulum unfolded protein response in neurodegenerative disorders and its potential therapeutic significance","volume":"10","author":"Remondelli","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"74","author":"Schroder","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.02856","article-title":"Beyond lectins: the calnexin\/calreticulin chaperone system of the endoplasmic reticulum","volume":"119","author":"Williams","year":"2006","journal-title":"J Cell Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R700048200","article-title":"Getting in and out from calnexin\/calreticulin cycles","volume":"283","author":"Caramelo","year":"2008","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.12.011","article-title":"Calnexin is essential for rhodopsin maturation, Ca2+ regulation, and photoreceptor cell survival","volume":"49","author":"Rosenbaum","year":"2006","journal-title":"Neuron"},{"key":"B65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0968-0004(02)00004-X","article-title":"Lectin control of protein folding and sorting in the secretory pathway","volume":"28","author":"Schrag","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.9.4697","article-title":"The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins","volume":"270","author":"Ware","year":"1995","journal-title":"J Biol Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3390001","article-title":"The protein disulphide-isomerase family: unravelling a string of folds","volume":"339","author":"Ferrari","year":"1999","journal-title":"Biochem J"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200602046","article-title":"Protein disulfide isomerase-like proteins play opposing roles during retrotranslocation","volume":"173","author":"Forster","year":"2006","journal-title":"J Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.780742","article-title":"Folding of a single domain protein entering the endoplasmic reticulum precedes disulfide formation","volume":"292","author":"Robinson","year":"2017","journal-title":"J Biol Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10172","article-title":"Proteins of the PDI family: unpredicted non-ER locations and functions","volume":"193","author":"Turano","year":"2002","journal-title":"J Cell Physiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1021\/bi002699r","article-title":"Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus","volume":"40","author":"Morello","year":"2001","journal-title":"Biochemistry"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15330","article-title":"Calnexin cycle - structural features of the ER chaperone system","volume":"287","author":"Kozlov","year":"2020","journal-title":"FEBS J"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.06.024","article-title":"Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function","volume":"382","author":"Ulloa-Aguirre","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.75.103004.142738","article-title":"Structure and mechanism of the Hsp90 molecular chaperone machinery","volume":"75","author":"Pearl","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1121","article-title":"Chaperoning G protein-coupled receptors: from cell biology to therapeutics","volume":"35","author":"Tao","year":"2014","journal-title":"Endocr Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.142257","article-title":"ANKRD13C acts as a molecular chaperone for G protein-coupled receptors","volume":"285","author":"Parent","year":"2010","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.054064","article-title":"Mu-opioid receptor cell surface expression is regulated by its direct interaction with ribophorin I","volume":"75","author":"Ge","year":"2009","journal-title":"Mol Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.08.009","article-title":"An ATIPical family of angiotensin II AT2 receptor-interacting proteins","volume":"21","author":"Rodrigues-Ferreira","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2006.00504.x","article-title":"Golgin-160 promotes cell surface expression of the beta-1 adrenergic receptor","volume":"7","author":"Hicks","year":"2006","journal-title":"Traffic"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins","volume":"278","author":"Christopoulos","year":"2003","journal-title":"J Biol Chem"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/383637a0","article-title":"Cyclophilin-related protein RanBP2 acts as chaperone for red\/green opsin","volume":"383","author":"Ferreira","year":"1996","journal-title":"Nature."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81173-3","article-title":"Odorant receptor localization to olfactory cilia is mediated by ODR-4, a novel membrane-associated protein","volume":"93","author":"Dwyer","year":"1998","journal-title":"Cell."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005433200","article-title":"Olfactory receptor trafficking involves conserved regulatory steps","volume":"276","author":"Gimelbrant","year":"2001","journal-title":"J Biol Chem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004082","article-title":"An ER complex of ODR-4 and ODR-8\/Ufm1 specific protease 2 promotes GPCR maturation by a Ufm1-independent mechanism","volume":"10","author":"Chen","year":"2014","journal-title":"PloS Genet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"102021","DOI":"10.1016\/j.jbc.2022.102021","article-title":"Human C1orf27 protein interacts with alpha2A-adrenergic receptor and regulates its anterograde transport","volume":"298","author":"Xu","year":"2022","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/ng1501","article-title":"Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2","volume":"37","author":"Metherell","year":"2005","journal-title":"Nat Genet"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708916105","article-title":"Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers","volume":"104","author":"Sebag","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.11.021","article-title":"RTP family members induce functional expression of mammalian odorant receptors","volume":"119","author":"Saito","year":"2004","journal-title":"Cell."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/35074561","article-title":"Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein","volume":"3","author":"Bermak","year":"2001","journal-title":"Nat Cell Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12624","article-title":"Mechanisms of the anterograde trafficking of GPCRs: Regulation of AT1R transport by interacting proteins and motifs","volume":"20","author":"Zhang","year":"2019","journal-title":"Traffic"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2011.04.012","article-title":"Protein quality control at the plasma membrane","volume":"23","author":"Okiyoneda","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.8.10.4063-4070.1988","article-title":"Reduction of endogenous GRP78 levels improves secretion of a heterologous protein in CHO cells","volume":"8","author":"Dorner","year":"1988","journal-title":"Mol Cell Biol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M611530200","article-title":"Rescue of a nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutant by cell-penetrating peptides","volume":"282","author":"Oueslati","year":"2007","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.celrep.2019.05.033","article-title":"Specific TBC domain-containing proteins control the ER-golgi-plasma membrane trafficking of GPCRs","volume":"28","author":"Wei","year":"2019","journal-title":"Cell Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2012.01351.x","article-title":"A triple arg motif mediates alpha(2B)-adrenergic receptor interaction with Sec24C\/D and export","volume":"13","author":"Dong","year":"2012","journal-title":"Traffic"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2008.01.014","article-title":"Endoplasmic reticulum export of adrenergic and angiotensin II receptors is differentially regulated by Sar1 GTPase","volume":"20","author":"Dong","year":"2008","journal-title":"Cell Signal"},{"key":"B97","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.tips.2011.09.002","article-title":"Small GTPase regulation of GPCR anterograde trafficking","volume":"33","author":"Wang","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.10.011","article-title":"The GTPase Rab43 controls the anterograde ER-golgi trafficking and sorting of GPCRs","volume":"21","author":"Li","year":"2017","journal-title":"Cell Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220679","article-title":"A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling","volume":"143","author":"Leclerc","year":"2002","journal-title":"Endocrinology."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M510180200","article-title":"Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b\/V3 receptor by a pharmacological chaperone","volume":"280","author":"Robert","year":"2005","journal-title":"J Biol Chem"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410655200","article-title":"A novel c-terminal motif is necessary for the export of the vasopressin V1b\/V3 receptor to the plasma membrane","volume":"280","author":"Robert","year":"2005","journal-title":"J Biol Chem"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1051\/jbio:2005037","article-title":"[Vasopressin receptors: structure\/function relationships and signal transduction in target cells]","volume":"199","author":"Robert","year":"2005","journal-title":"J Soc Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.08.043","article-title":"The hydrophobic amino acid residues in the membrane-proximal c tail of the G protein-coupled vasopressin V2 receptor are necessary for transport-competent receptor folding","volume":"579","author":"Thielen","year":"2005","journal-title":"FEBS Lett"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.051623","article-title":"Anterograde trafficking of G protein-coupled receptors: function of the c-terminal F(X)6LL motif in export from the endoplasmic reticulum","volume":"75","author":"Duvernay","year":"2009","journal-title":"Mol Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313881200","article-title":"A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface","volume":"279","author":"Duvernay","year":"2004","journal-title":"J Biol Chem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-04-01189.2001","article-title":"C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors","volume":"21","author":"Pagano","year":"2001","journal-title":"J Neurosci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5502.316","article-title":"Role of ER export signals in controlling surface potassium channel numbers","volume":"291","author":"Ma","year":"2001","journal-title":"Science."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2010.01033.x","article-title":"Regulation of G-protein coupled receptor traffic by an evolutionary conserved hydrophobic signal","volume":"11","author":"Angelotti","year":"2010","journal-title":"Traffic."},{"key":"B109","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4331\/wjbc.v3.i4.61","article-title":"Modulation of cell surface GABA(B) receptors by desensitization, trafficking and regulated degradation","volume":"3","author":"Benke","year":"2012","journal-title":"World J Biol Chem"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020961","article-title":"Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism","volume":"87","author":"Leanos-Miranda","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M605734200","article-title":"Regulation of anterograde transport of alpha2-adrenergic receptors by the n termini at multiple intracellular compartments","volume":"281","author":"Dong","year":"2006","journal-title":"J Biol Chem"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2009.00890.x","article-title":"A single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors","volume":"10","author":"Duvernay","year":"2009","journal-title":"Traffic"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.73.011303.073752","article-title":"Roles of n-linked glycans in the endoplasmic reticulum","volume":"73","author":"Helenius","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20050189","article-title":"Importance of n-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human AT1 receptor","volume":"390","author":"Lanctot","year":"2005","journal-title":"Biochem J"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/8.4.311","article-title":"Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation","volume":"8","author":"Rannikko","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1677\/JME-08-0114","article-title":"G-Protein-coupled receptors, cholesterol and palmitoylation: facts about fats","volume":"42","author":"Chini","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00076","article-title":"Role of cysteine residues in the carboxyl-terminus of the follicle-stimulating hormone receptor in intracellular traffic and postendocytic processing","volume":"4","author":"Melo-Nava","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0335","article-title":"Evidence that palmitoylation of carboxyl terminus cysteine residues of the human luteinizing hormone receptor regulates postendocytic processing","volume":"19","author":"Munshi","year":"2005","journal-title":"Mol Endocrinol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7258(02)00300-5","article-title":"Role of palmitoylation\/depalmitoylation reactions in G-protein-coupled receptor function","volume":"97","author":"Qanbar","year":"2003","journal-title":"Pharmacol Ther"},{"key":"B121","doi-asserted-by":"publisher","first-page":"re14","DOI":"10.1126\/stke.3592006re14","article-title":"Palmitoylation of ligands, receptors, and intracellular signaling molecules","volume":"2006","author":"Resh","year":"2006","journal-title":"Sci STKE"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2006.09.021","article-title":"G protein-coupled receptor dimerisation: molecular basis and relevance to function","volume":"1768","author":"Milligan","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.42.091701.082314","article-title":"Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function","volume":"42","author":"Angers","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200729200","article-title":"Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer","volume":"277","author":"Ayoub","year":"2002","journal-title":"J Biol Chem"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2009.09.023","article-title":"Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors","volume":"22","author":"Guan","year":"2010","journal-title":"Cell Signal"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200679200","article-title":"The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer","volume":"278","author":"Guo","year":"2003","journal-title":"J Biol Chem"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1021\/bi048398p","article-title":"Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells","volume":"43","author":"Herrick-Davis","year":"2004","journal-title":"Biochemistry"},{"key":"B128","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1095\/biolreprod.114.125781","article-title":"Single-molecule analyses of fully functional fluorescent protein-tagged follitropin receptor reveal homodimerization and specific heterodimerization with lutropin receptor","volume":"92","author":"Mazurkiewicz","year":"2015","journal-title":"Biol Reprod"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008902200","article-title":"Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. the human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy","volume":"276","author":"McVey","year":"2001","journal-title":"J Biol Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205767200","article-title":"Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer","volume":"277","author":"Mercier","year":"2002","journal-title":"J Biol Chem"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403363200","article-title":"Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting","volume":"279","author":"Salahpour","year":"2004","journal-title":"J Biol Chem"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400052","article-title":"Roles of G-protein-coupled receptor dimerization","volume":"5","author":"Terrillon","year":"2004","journal-title":"EMBO Rep"},{"key":"B133","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0896-6273(00)00012-X","article-title":"A trafficking checkpoint controls GABA(B) receptor heterodimerization","volume":"27","author":"Margeta-Mitrovic","year":"2000","journal-title":"Neuron."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.49.30603","article-title":"Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32","volume":"272","author":"Benkirane","year":"1997","journal-title":"J Biol Chem"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.4.677","article-title":"The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors","volume":"58","author":"Karpa","year":"2000","journal-title":"Mol Pharmacol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030084","article-title":"Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans","volume":"88","author":"Leanos-Miranda","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.1.120","article-title":"Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell","volume":"58","author":"Lee","year":"2000","journal-title":"Mol Pharmacol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.02.027","article-title":"Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. rescue of oligomerization-dependent defective receptor expression by using cognate decoys","volume":"321","author":"Zarinan","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1021\/bi981162z","article-title":"Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function","volume":"37","author":"Zhu","year":"1998","journal-title":"Biochemistry."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1124\/pr.59.3.2","article-title":"G Protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo","volume":"59","author":"Conn","year":"2007","journal-title":"Pharmacol Rev"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00759.x","article-title":"Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones","volume":"12","author":"Cheong","year":"2007","journal-title":"Nephrol (Carlton)"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.63.1.607","article-title":"Nephrogenic diabetes insipidus","volume":"63","author":"Morello","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200721030-00003","article-title":"Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application","volume":"21","author":"Robben","year":"2007","journal-title":"BioDrugs."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900130106","article-title":"Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists","volume":"106","author":"Robben","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B145","article-title":"Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus","volume":"55","author":"Bichet","year":"1994","journal-title":"Am J Hum Genet"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Fujiwara","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100051","article-title":"Molecular and cellular defects in nephrogenic diabetes insipidus","volume":"16","author":"Knoers","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J Clin Invest"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.11.003","article-title":"Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs","volume":"21","author":"Conn","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.556381","article-title":"Functional rescue of kallmann syndrome-associated prokineticin receptor 2 (PKR2) mutants deficient in trafficking","volume":"289","author":"Chen","year":"2014","journal-title":"J Biol Chem"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2071","article-title":"In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles","volume":"90","author":"Leanos-Miranda","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-4765-4_14","article-title":"Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target","volume":"63","author":"Maya-Nunez","year":"2012","journal-title":"Subcell Biochem"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0388","article-title":"Clinical lessons from the calcium-sensing receptor","volume":"3","author":"Brown","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68578","article-title":"Structural insights into the activation of human calcium-sensing receptor","volume":"10","author":"Chen","year":"2021","journal-title":"Elife"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.11.006","article-title":"Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations","volume":"22","author":"Egbuna","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1210\/me.2009-0041","article-title":"Pharmacochaperone-mediated rescue of calcium-sensing receptor loss-of-function mutants","volume":"23","author":"White","year":"2009","journal-title":"Mol Endocrinol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.10.3471","article-title":"Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism","volume":"82","author":"Biebermann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1093\/hmg\/ddi329","article-title":"Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance","volume":"14","author":"Calebiro","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.3.6460","article-title":"Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: Evidence for a new inactivating mutation of the TSH receptor gene","volume":"85","author":"Tonacchera","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02709.x","article-title":"Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia","volume":"66","author":"Lin","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2005.10.006","article-title":"Inherited ACTH insensitivity illuminates the mechanisms of ACTH action","volume":"16","author":"Clark","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"B162","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1152\/physrev.00029.2016","article-title":"Pharmacoperones as novel therapeutics for diverse protein conformational diseases","volume":"98","author":"Tao","year":"2018","journal-title":"Physiol Rev"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0037","article-title":"The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology","volume":"31","author":"Tao","year":"2010","journal-title":"Endocr Rev"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1530\/JME-14-0184","article-title":"Functions of the DRY motif and intracellular loop 2 of human melanocortin 3 receptor","volume":"53","author":"Huang","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0524","article-title":"Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity","volume":"144","author":"Tao","year":"2003","journal-title":"Endocrinology"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.7.3070","article-title":"Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration","volume":"92","author":"Colley","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.1309","article-title":"Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia","volume":"87","author":"D'Souza-Li","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401945","article-title":"Functional characterization of three mutations of the endothelin b receptor gene in patients with hirschsprung's disease: evidence for selective loss of gi coupling","volume":"7","author":"Fuchs","year":"2001","journal-title":"Mol Med"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab134","article-title":"Rescue of cell surface expression and signalling of mutant follicle-stimulating hormone receptors","volume":"162","author":"Hanyroup","year":"2021","journal-title":"Endocrinology"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1159\/000508000","article-title":"Rescue of function of mutant luteinising hormone receptors with deficiencies in cell surface expression, hormone binding, and hormone signalling","volume":"111","author":"Newton","year":"2021","journal-title":"Neuroendocrinology"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.09.015","article-title":"Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine","volume":"298","author":"Janovick","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B172","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-819132-3.00016-6","article-title":"Cellular high-throughput screening","volume-title":"Protein homeostasis deseases","author":"Janovick","year":"2020"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8386","article-title":"Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site","volume":"87","author":"Maya-Nunez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207526","article-title":"Molecular dynamics simulation of the follicle-stimulating hormone receptor. understanding the conformational dynamics of receptor variants at positions N680 and D408 from in silico analysis","volume":"13","author":"Jardon-Valadez","year":"2018","journal-title":"PloS One"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1210\/mend.12.2.0056","article-title":"Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation","volume":"12","author":"Lin","year":"1998","journal-title":"Mol Endocrinol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa782","article-title":"A novel mutation in the FSH receptor (I423T) affecting receptor activation and leading to primary ovarian failure","volume":"106","author":"Zarinan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1210\/mend.13.6.0291","article-title":"Influence of a species-specific extracellular amino acid on expression and function of the human gonadotropin-releasing hormone receptor","volume":"13","author":"Arora","year":"1999","journal-title":"Mol Endocrinol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1210\/me.2012-1072","article-title":"Mice harboring gnrhr E90K, a mutation that causes protein misfolding and hypogonadotropic hypogonadism in humans, exhibit testis size reduction and ovulation failure","volume":"26","author":"Stewart","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/endo.138.1.4902","article-title":"Temperature sensitivity of some mutants of the lutropin\/choriogonadotropin receptor","volume":"138","author":"Jaquette","year":"1997","journal-title":"Endocrinology"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1124\/mol.60.6.1195","article-title":"Cooling evokes redistribution of alpha2C-adrenoceptors from golgi to plasma membrane in transfected human embryonic kidney 293 cells","volume":"60","author":"Jeyaraj","year":"2001","journal-title":"Mol Pharmacol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)60659-3","article-title":"Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding","volume":"263","author":"Machamer","year":"1988","journal-title":"J Biol Chem"},{"key":"B182","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/JME-12-0051","article-title":"Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones","volume":"49","author":"Yu","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/358761a0","article-title":"Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive","volume":"358","author":"Denning","year":"1992","journal-title":"Nature."},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2010.11.020","article-title":"Modulation of alpha(2C) adrenergic receptor temperature-sensitive trafficking by HSP90","volume":"1813","author":"Filipeanu","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1007\/164_2017_49","article-title":"Intracellular trafficking of gonadotropin receptors in health and disease","author":"Ulloa-Aguirre","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2006.08.012","article-title":"Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs","volume":"1764","author":"Arakawa","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B187","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1210\/er.2004-0010","article-title":"Beyond the signal sequence: protein routing in health and disease","volume":"26","author":"Castro-Fernandez","year":"2005","journal-title":"Endocr Rev"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200212000-00004","article-title":"Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking","volume":"52","author":"Perlmutter","year":"2002","journal-title":"Pediatr Res"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911991107","article-title":"Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP\/Grp78","volume":"107","author":"Gorbatyuk","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1021\/cb500798y","article-title":"Classification of chemical chaperones based on their effect on protein folding landscapes","volume":"10","author":"Dandage","year":"2015","journal-title":"ACS Chem Biol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1210\/me.2008-0384","article-title":"Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: the GnRH receptor","volume":"23","author":"Janovick","year":"2009","journal-title":"Mol Endocrinol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160307143345","article-title":"Pharmacoperones as a new therapeutic approach: In vitro identification and In vivo validation of bioactive molecules","volume":"17","author":"Ulloa-Aguirre","year":"2016","journal-title":"Curr Drug Targets"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2013.11.005","article-title":"\"Pharmacoperone\": What's in a word","volume":"83","author":"Conn","year":"2013","journal-title":"Pharmacol Res"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.01.005","article-title":"Pharmacological chaperoning: a primer on mechanism and pharmacology","volume":"83","author":"Leidenheimer","year":"2014","journal-title":"Pharmacol Res"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408154200","article-title":"Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors","volume":"279","author":"Wuller","year":"2004","journal-title":"J Biol Chem"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1315194110","article-title":"Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy","volume":"110","author":"Janovick","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B197","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.phrs.2013.12.004","article-title":"Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens","volume":"83","author":"Conn","year":"2014","journal-title":"Pharmacol Res"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.048454","article-title":"Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor","volume":"305","author":"Janovick","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008121289","article-title":"Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus","volume":"20","author":"Jean-Alphonse","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3109\/10606820212134","article-title":"V2R structure and diabetes insipidus","volume":"8","author":"Birnbaumer","year":"2002","journal-title":"Receptors Channels"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00491.2005","article-title":"Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus","volume":"291","author":"Robben","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.nephro.2006.07.010","article-title":"[Nephrogenic diabetes insipidus]","volume":"2","author":"Bichet","year":"2006","journal-title":"Nephrol Ther"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/S0188-4409(99)00063-6","article-title":"Vasopressin receptor mutations and nephrogenic diabetes insipidus","volume":"30","author":"Birnbaumer","year":"1999","journal-title":"Arch Med Res"},{"key":"B204","article-title":"Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function","volume":"50","author":"Oksche","year":"1996","journal-title":"Mol Pharmacol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1210\/er.2012-1044","article-title":"Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment","volume":"34","author":"Moeller","year":"2013","journal-title":"Endocr Rev"},{"key":"B206","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/hmg\/ddh105","article-title":"Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo","volume":"13","author":"Sangkuhl","year":"2004","journal-title":"Hum Mol Genet"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J Clin Invest"},{"key":"B208","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejphar.2010.12.025","article-title":"Physiological roles of the melanocortin MC(3) receptor","volume":"660","author":"Renquist","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00726.x","article-title":"Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients","volume":"13","author":"Fan","year":"2009","journal-title":"J Cell Mol Med"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.03.001","article-title":"Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity","volume":"1863","author":"Huang","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132778","article-title":"Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity","volume":"6","author":"Rene","year":"2021","journal-title":"JCI Insight"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609045200","article-title":"Rescue of calcium-sensing receptor mutants by allosteric modulators reveals a conformational checkpoint in receptor biogenesis","volume":"282","author":"Huang","year":"2007","journal-title":"J Biol Chem"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2582","article-title":"Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes","volume":"95","author":"Sykiotis","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B214","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/hmg\/ddn318","article-title":"PROKR2 missense mutations associated with kallmann syndrome impair receptor signalling activity","volume":"18","author":"Monnier","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B215","article-title":"Mutations of gonadotropin-releasing hormone receptor gene","volume-title":"Encyclopedia of endocrine diseases","author":"Ulloa-Aguirre AZ","year":"2019"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.04.018","article-title":"GnRH receptor mutations in isolated gonadotropic deficiency","volume":"346","author":"Chevrier","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S1472-6483(10)61901-3","article-title":"Biochemical and functional aspects of gonadotrophin-releasing hormone and gonadotrophins","volume":"1","author":"Ulloa-Aguirre","year":"2000","journal-title":"Reprod BioMed Online"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.7.8582","article-title":"Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target","volume":"87","author":"Janovick","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/164_2017_49","article-title":"Intracellular trafficking of gonadotropin receptors in health and disease","volume":"245","author":"Ulloa-Aguirre","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:26:3:207","article-title":"Mutations in human gonadotropin and gonadotropin-receptor genes","volume":"26","author":"Huhtaniemi","year":"2005","journal-title":"Endocrine."},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1038\/ng0297-205","article-title":"Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility","volume":"15","author":"Tapanainen","year":"1997","journal-title":"Nat Genet"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3795","article-title":"A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor","volume":"102","author":"Beau","year":"1998","journal-title":"J Clin Invest"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90275-9","article-title":"Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure","volume":"82","author":"Aittomaki","year":"1995","journal-title":"Cell."},{"key":"B224","first-page":"9","article-title":"[Inherited primary amenorrhea. the first gynecological disease of Finnish heritage]","volume":"112","author":"Aittomaki","year":"1996","journal-title":"Duodecim."},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015723108","article-title":"Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist","volume":"108","author":"Newton","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1002\/1439-7633(20021004)3:10<1023::AID-CBIC1023>3.0.CO;2-9","article-title":"The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction","volume":"3","author":"van Straten","year":"2002","journal-title":"Chembiochem."},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-011-9176-2","article-title":"Novel pathways in gonadotropin receptor signaling and biased agonism","volume":"12","author":"Ulloa-Aguirre","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2011.00006","article-title":"Pharmacoperone identification for therapeutic rescue of misfolded mutant proteins","volume":"2","author":"Conn","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1177\/1087057113483559","article-title":"High-throughput screen for pharmacoperones of the vasopressin type 2 receptor","volume":"18","author":"Conn","year":"2013","journal-title":"J Biomol Screen"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1177\/2472555217689992","article-title":"Drug library screening for the identification of ionophores that correct the mistrafficking disorder associated with oxalosis kidney disease","volume":"22","author":"Hou","year":"2017","journal-title":"SLAS Discov"},{"key":"B231","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1089\/adt.2014.627","article-title":"Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screening","volume":"13","author":"Madoux","year":"2015","journal-title":"Assay Drug Dev Technol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-391862-8.00001-6","article-title":"Therapeutic rescue of Misfolded\/Mistrafficked mutants: Automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRs","volume":"521","author":"Smithson","year":"2013","journal-title":"Methods Enzymol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20180065","article-title":"Chemical validation and optimization of pharmacoperones targeting vasopressin type 2 receptor mutant","volume":"475","author":"Janovick","year":"2018","journal-title":"Biochem J"},{"key":"B234","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1042\/ETLS20180055","article-title":"Modulation of proteostasis and protein trafficking: a therapeutic avenue for misfolded G protein-coupled receptors causing disease in humans","volume":"3","author":"Ulloa-Aguirre","year":"2019","journal-title":"Emerg Top Life Sci"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200312018","article-title":"Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes","volume":"164","author":"Sharma","year":"2004","journal-title":"J Cell Biol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis","volume":"73","author":"Welsh","year":"1993","journal-title":"Cell"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90241-4","article-title":"Multiple proteolytic systems, including the proteasome, contribute to CFTR processing","volume":"83","author":"Jensen","year":"1995","journal-title":"Cell."},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1038\/35050509","article-title":"The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation","volume":"3","author":"Meacham","year":"2001","journal-title":"Nat Cell Biol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90240-6","article-title":"Degradation of CFTR by the ubiquitin-proteasome pathway","volume":"83","author":"Ward","year":"1995","journal-title":"Cell."},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2013.04.020","article-title":"Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis","volume":"17","author":"Birault","year":"2013","journal-title":"Curr Opin Chem Biol"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2014.02.021","article-title":"VX-809 and related corrector compounds exhibit secondary activity stabilizing active F508del-CFTR after its partial rescue to the cell surface","volume":"21","author":"Eckford","year":"2014","journal-title":"Chem Biol"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-Tezacaftor-Ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20060013","article-title":"The chemical chaperone CFcor-325 repairs folding defects in the transmembrane domains of CFTR-processing mutants","volume":"395","author":"Loo","year":"2006","journal-title":"Biochem J"},{"key":"B244","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bcp.2017.03.020","article-title":"Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR","volume":"136","author":"Loo","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"B245","article-title":"CFTR modulators for the treatment of cystic fibrosis","volume":"39","author":"Pettit","year":"2014","journal-title":"P T"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"B247","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discov and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discovery Today"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.11.037","article-title":"Artificial intelligence in drug discovery: what is realistic, what are illusions? part 2: a discussion of chemical and biological data","volume":"26","author":"Bender","year":"2021","journal-title":"Drug Discov Today"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.12.009","article-title":"Artificial intelligence in drug discovery: what is realistic, what are illusions? part 1: Ways to make an impact, and why we are not there yet","volume":"26","author":"Bender","year":"2021","journal-title":"Drug Discov Today"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1539","article-title":"A high-throughput screening method for small-molecule pharmacologic chaperones of misfolded rhodopsin","volume":"49","author":"Noorwez","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34355","article-title":"Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria","volume":"118","author":"Pey","year":"2008","journal-title":"J Clin Invest"},{"key":"B253","doi-asserted-by":"publisher","first-page":"10579","DOI":"10.1038\/s41598-020-67473-w","article-title":"Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity","volume":"10","author":"Smith","year":"2020","journal-title":"Sci Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.934685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T05:33:19Z","timestamp":1661405599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.934685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":253,"alternative-id":["10.3389\/fendo.2022.934685"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.934685","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"934685"}}